Idenix (IDIX) was halted, news pending, and is off $2.33 to $5.98 after the company said its IDX184 has been placed on a partial hold by the FDA. Shares are reeling and a 2000-lot of Oct 10 calls trades on the biotech for 20 cents. An investor bought-to-close, according to ISEE. A separate 1000-lot of Sep 9 calls was also bought-to-close on IDIX for a dime on ISE. 3770 calls and 230 puts traded on the stock and 30-day ATM implied volatility is up 4 percent to 72.5.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.